The U.S. market is projected to reach USD 639.13 Million by 2035 from USD 357.90 Million in 2025, while Europe remains a key regional market driven by AI adoption and cancer screening.
Austin, United States, Aug. 12, 2026 (GLOBE NEWSWIRE) — The Computer Aided Detection Market was valued at USD 901.22 Million in 2025 and is projected to reach USD 1.62 Billion by 2035, growing at a CAGR of 6.04% during 2026–2035, according to a new report by SNS Insider.
With an increase in the occurrence of cancers of the breast, lungs, colon, and prostate glands, there has been an ever-increasing demand for Computer Aided Detection Systems in the global market. Increased diagnosis has led to increased use of CAD technology in hospitals and diagnostic centers as a result of cancer-screening programs both governmental and privately funded.
Download the Computer Aided Detection Market Sample Report: https://www.snsinsider.com/sample-request/8504
Key Takeaways:
- Leading Technology: Machine Learning-Based CAD (~40.87% share)
- Leading Imaging Modality: Mammography (~33.88% share)
- Leading Application: Breast Cancer (~34.89% share)
- Leading End User: Hospitals (~57.85% share)
- Largest Regional Market: North America (~46.60% share)
- Fastest-Growing Regional Market: Asia Pacific (6.94% CAGR)
Cancer Screening and AI Adoption Drive Computer Aided Detection Market Growth
CAD technology is greatly affected by the increase in screening campaigns and awareness regarding disease diagnosis. Campaigns aimed at breast, lung, and colorectal cancer screening conducted by government and private organizations have pushed hospitals and diagnostic clinics to use CAD systems. Awareness regarding the issue on the part of patients has forced health care organizations to implement CAD technology using artificial intelligence. According to the Centers for Disease Control and Prevention, mammography rates among women in the United States have increased to 75%, which was 72% in 2023.
Computer Aided Detection Market Segmentation Insights
By Technology
Machine Learning-Based CAD emerged as the leading segment accounting for about 40.87% market share in 2025 due to its capability to analyze huge volumes of images, high accuracy of diagnosis, and fewer false positive results in imaging techniques. The fastest growing segment is that of Deep Learning-Based CAD having 6.53% CAGR owing to better predictive analysis and image interpretation.
By Imaging Modality
The mammography market is the leading one with an estimated 33.88% share in 2025 owing to factors such as high incidence of breast cancer, government screenings, and increasing use of new-age 3D imaging technology that helps detect breast cancer at an early stage. Tomosynthesis and Nuclear Imaging is the fastest growing segment with a 6.83% CAGR driven by better lesion detection, screening activities, and AI assistance.
By Application
Breast Cancer took the lead position with a market share of 34.89% in 2025 owing to the increasing incidences, availability of mammography and tomosynthesis screening, increased awareness of patients, and use of artificial intelligence-based computer-aided detection systems. The fastest-growing application is Lung Cancer with a CAGR of 6.81% due to the increased prevalence and the use of low-dose CT screening and artificial intelligence-based systems.
By End User
Hospitals accounted for nearly 57.85% share in 2025 owing to high volume of patients, multipurpose imaging units, and increased use of AI-based Computer Aided Detection systems to achieve better accuracy and efficiency of work. The Diagnostic Centers end-user category is the fastest growing at 6.53% CAGR on account of increasing numbers of imaging centers and need for quick and accurate diagnostic tests at affordable costs.
Computer Aided Detection Market Regional Analysis:
The North American region was the leading region in terms of CAD software market share, accounting for 46.60% in 2025, attributed to the presence of advanced healthcare infrastructure, high incidences of cancer and chronic disease cases, and an early acceptance of artificial intelligence and deep learning technology. The dominance is further attributed to the availability of favorable government support, reimbursement policy, and healthcare IT spending in the region.
The U.S. Computer Aided Detection Market was valued at USD 357.90 Million in 2025 and is projected to reach USD 639.13 Million by 2035, growing at a CAGR of 5.97% during 2026–2035. The U.S. market benefits from advanced healthcare infrastructure, established cancer screening programs, and increasing adoption of AI-enabled medical imaging technologies.
The Europe Computer Aided Detection Market is estimated to be USD 234.32 Million in 2025 and is projected to reach USD 405.86 Million by 2035, growing at a CAGR of 5.64% during 2026–2035.. Europe is considered as the second-largest market owing to its advanced health care facilities, high incidences of cancer cases, and early adoption of AI imaging solutions. Germany is the largest country in the Europe region because of advanced AI diagnostics, strong cancer screening practices, and government strategies for early disease diagnosis.
Asia Pacific is expected to show the fastest growth rate of 6.94% because of the growth in healthcare infrastructure, rising numbers of government screening programs, and patient awareness about the early detection of cancers. The largest regional market is China because of the growth in healthcare infrastructure, CAD using artificial intelligence and deep learning, and government cancer screening programs.
Explore the Complete Computer Aided Detection Market Report: https://www.snsinsider.com/reports/computer-aided-detection-market-8504
Leading Companies in the Computer Aided Detection Market:
- Siemens Healthineers
- GE Healthcare
- Philips Healthcare
- Hologic, Inc.
- iCAD, Inc.
- Fujifilm Holdings Corporation
- Canon Medical Systems Corporation
- Agfa-Gevaert Group
- Medtronic plc
- ContextVision AB
- Carestream Health
- Riverain Technologies
- Qure.ai
- Infervision
- Zebra Medical Vision
- Lunit Inc.
- Koios Medical
- RadNet, Inc.
- RadNet, Inc.
- Samsung Medison Co., Ltd.
Recent Developments:
- April 2025: Siemens Healthineers launched AI-Rad Companion Chest CT, an AI-powered CAD tool for automated lung and cardiovascular analysis, improving diagnostic accuracy and workflow efficiency.
- January 2025: GE Healthcare introduced Revolution Apex AI, a CAD-enhanced imaging platform integrating deep learning algorithms for early cancer detection across oncology and cardiology imaging.
Frequently Asked Questions
Q: What is the current size of the Computer Aided Detection Market?
A: The market was valued at USD 901.22 million in 2025.
Q: What is the projected size of the Computer Aided Detection Market by 2035??
A: The market is projected to reach USD 1620.05 million by 2035.
Q: What is the expected CAGR of the Computer Aided Detection Market?
A: The market is expected to grow at a CAGR of 6.04% from 2026 to 2035.
Q: What is Computer Aided Detection used for?
A: CAD systems assist radiologists in detecting cancers and chronic diseases, including breast, lung, colorectal, and prostate cancers, through AI-enhanced imaging analysis.
Q: What factors are driving growth in the Computer Aided Detection Market?
A: Rising cancer prevalence, expanding screening programs, and advancements in AI and deep learning imaging technologies are the primary growth drivers.
Buy the Computer Aided Detection Market Report with Competitive Analysis and 2035 Forecast: https://www.snsinsider.com/checkout/8504
Computer Aided Detection Market Report Scope
| Report Attributes | Details |
| Market Size in 2025 | USD 901.22 Million |
| Market Size by 2035 | USD 1620.05 Million |
| CAGR | CAGR of 6.04% From 2026 to 2035 |
| Base Year | 2025 |
| Forecast Period | 2026-2035 |
| Historical Data | 2022-2024 |
| Key Segments | • By Imaging Modalities (Mammography, Magnetic Resonance Imaging, Ultrasound Imaging, Tomosynthesis Nuclear Imaging) • By Application (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Liver Cancer, Bone Cancer) • By Technology (Machine Learning-Based CAD, Deep Learning-Based CAD, Traditional CAD) • By End User (Hospitals, Diagnostic Centers, Research Centers) |
| Regional Analysis/Coverage | North America (US, Canada), Europe (Germany, UK, France, Italy, Spain, Russia, Poland, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN Countries, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Mexico, Colombia, Rest of Latin America). |
Recently Published Press Releases
Companion Animal Health Market Size To Exceed $66.0 Billion By 2035
Pet Boarding Services Market Size To Exceed $19.59 Billion By 2035
Fecal Calprotectin Testing Market Size To Exceed $17.00 Billion By 2035
Chemiluminescence Immunoassay Market Size To Exceed $20.32 Billion By 2035
Transplant Diagnostics Market Size To Exceed $12.70 Billion By 2035
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company’s aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
CONTACT: Contact Us: Rohan Jadhav - Principal Consultant Phone: +1-315-961-9094 (US) Email: info@snsinsider.com
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. IndiaEveningPost.com takes no editorial responsibility for the same.